Validated HPTLC method for simultaneous estimation of levofloxacin hemihydrate and ornidazole in pharmaceutical dosage form.
A simple, rapid, and accurate high-performance thin-layer chromatography (HPTLC) method is described for the simultaneous determination of levofloxacin hemihydrate and ornidazole in tablet dosage form. The method is based on the HPTLC separation of the two drugs followed by densitometric measurements of their spots at 298 nm. The separation is carried out on Merck TLC aluminium sheets of silica gel 60 F254 using n-butanol-methanol-ammonia (5:1:1.5, v/v/v) as mobile phase. The linearity is found to be in the range of 50-250 and 100-500 ng/spot for levofloxacin hemihydrate and ornidazole, respectively. The method is successively applied to pharmaceutical formulation because no chromatographic interferences from the tablet excipients are found. The suitability of this HPTLC method for the quantitative determination of the compounds is proved by validation in accordance with the requirements laid down by International Conference on Harmonization (ICH) guidelines.
Chepurwar
S B
SB
Department of Pharmaceutical Analytical Chemistry, R.C. Patel College of Pharmacy, Shirpur, Dist-Dhule, Maharashtra State, India.
Shirkhedkar
A A
AA
Bari
S B
SB
Fursule
R A
RA
Surana
S J
SJ
D000563:Amebicides / Q000032:analysis*; D000900:Anti-Bacterial Agents / Q000032:analysis*; D002138:Calibration; D002855:Chromatography, Thin Layer / Q000379:methods*; D004304:Dosage Forms; D064704:Levofloxacin; D015242:Ofloxacin / Q000032:analysis*; D009950:Ornidazole / Q000032:analysis*; D012015:Reference Standards; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D000563:Amebicides; D000900:Anti-Bacterial Agents; D004304:Dosage Forms; D009950:Ornidazole; D064704:Levofloxacin; D015242:Ofloxacin